Related Experiment Video
Updated: Jan 19, 2026

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
Published on: October 2, 2018
Hyperandrogenism and Adrenocortical Tumors
1Division of Endocrinology, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, S. Orsola Malpighi Hospital, Bologna, Italy, guido.didalmazi@unibo.it.
Androgen-secreting tumors, rare causes of adrenal hyperandrogenism, are often adrenocortical carcinomas. These tumors frequently elevate multiple androgens, including androstenedione, DHEAS, and testosterone.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Androgen-secreting tumors are a rare cause of hyperandrogenism.
- Adrenocortical carcinomas account for two-thirds of these rare tumors.
- Elevated androgens like androstenedione, DHEAS, and testosterone are common.
Purpose of the Study:
- To provide a comprehensive review of androgen-secreting tumors.
- Focus on epidemiology, clinical presentation, and hormonal profiles.
- Summarize research from the last 20 years.
Main Methods:
- Literature review of studies published in the last 20 years.
- Analysis of epidemiological data.
- Review of clinical presentations and hormonal profiles.
Main Results:
- Androgen-secreting tumors are rare, <2% of hyperandrogenism cases.
- Adrenocortical carcinomas are the predominant type (2/3).
- Over half of patients show elevated androstenedione, DHEAS, and testosterone.
Conclusions:
- Despite advances, no specific driver molecular event identified in these tumors.
- Understanding epidemiology and hormonal profiles is crucial for diagnosis.
- Further research into pathogenesis is needed.
Related Concept Videos
08:20A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
04:33Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions
08:42Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
10:04Enhancing Tumor Content through Tumor Macrodissection
08:00The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
07:49Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model

